MINX is a 5 mg oral minoxidil capsule. We developed the formulation to explore whether it could smoothen minoxidil release in vitro compared with an immediate-release comparator.

What are the potential side effects of MINX?

Oral minoxidil may cause an increased heart rate, irregular heartbeat, swelling in the hands or feet, weight gain, and hypertrichosis or hirsutism. Other potential effects include initial hair shedding dizziness, fluid retention, and low blood pressure.

Who should not use MINX?

This formulation is suitable for both men and women. Women, particularly those who are pregnant or may become pregnant or are breast feeding, should avoid using this medication, as minoxidil could pose a risk to a developing fetus.

Take 1 capsule (5mg) orally once a day with water, with a meal, preferably at the same time each day for consistency.

What is the FDA approval status of MINX?

MINX is a compounded smooth-release oral minoxidil capsule that demonstrated an extended-release profile in observational testing. "Extended-release" is an FDA dosage-form designation, which cannot be claimed without comprehensive clinical trials. Neither MINX nor any other currently available oral minoxidil is FDA-approved for hair loss. MINX is available today after an online consultation. Compounded under §503A; prescription required. Compounded drugs are not FDA-reviewed for safety or effectiveness.

Where can I get extended release oral minoxidil today?

No FDA-approved extended-release oral minoxidil is on the market, but MINX was designed for and has demonstrated an extended-release profile in observational testing. It is available today after an online consultation.

Is MINX extended-release minoxidil?

MINX is designed for an extended-release profile. In Anagen's fed-state pilot, serum minoxidil was still rising at hour 8 after a 5 mg capsule taken with food. Anagen calls MINX "smooth-release," its own term for a compounded lipid-matrix capsule. The investigational extended-release tablet VDPHL01 is a different product and is not available.